| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |